Colitis, Ulcerative: all 1,530 studies

Page 6 of 16. Open to participants first (407), then studies with results posted, then the rest; newest registration first within each.

• Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative ColitisCompletedNCT03368118Phase 2Results posted
• Phase 2 Dose-finding IMU-838 for Ulcerative ColitisTerminatedNCT03341962Phase 2Results posted
• A Study to Determine the Pharmacokinetics (PK) of Single Intravenous (IV) Dose of Vedolizumab 300 Milligram (mg) in Healthy Adult Chinese ParticipantsCompletedNCT03329209Phase 1Results posted
• Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UCTerminatedNCT03298022Phase 2Results posted
• An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative ColitisCompletedNCT03290781Phase 3Results posted
• A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)CompletedNCT03283085Phase 3Results posted
• A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable RemissionTerminatedNCT03281304Phase 4Results posted
• Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.TerminatedNCT03269695Phase 2Results posted
• Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative ColitisTerminatedNCT03259334Phase 3Results posted
• Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative ColitisTerminatedNCT03259308Phase 3Results posted
• Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)CompletedNCT03196427Phase 2Results posted
• The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative ColitisCompletedNCT03178669Phase 2Results posted
• Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative ColitisTerminatedNCT03169894Phase 1Results posted
• Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)CompletedNCT03138655Phase 2Results posted
• Study of the Golimumab Exposure-Response Relationship Using Serum Trough LevelsCompletedNCT03124121Phase 4Results posted
• A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current TherapyCompletedNCT03123120Phase 2Results posted
• This Study Tests How BI 655130 Works in Patients With Active Ulcerative Colitis. The Study Also Tests How Well BI 655130 is Tolerated and Whether it Helps the PatientsCompletedNCT03100864Phase 2Results posted
• ABX464 in Subjects With Moderate to Severe Active Ulcerative ColitisCompletedNCT03093259Phase 2Results posted
• Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative ColitisCompletedNCT03029143Phase 4Results posted
• Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative ColitisCompletedNCT03018925Results posted
• Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative ColitisCompletedNCT02958865Phase 2Results posted
• Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UCTerminatedNCT02954159Phase 3Results posted
• Endovenous Corticosteroid Pulses in Moderate Ulcerative ColitisTerminatedNCT02921555Phase 4Results posted
• Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative ColitisCompletedNCT02914522Phase 3Results posted
• GSK2982772 Study in Subjects With Ulcerative ColitisCompletedNCT02903966Phase 2Results posted
• Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative ColitisTerminatedNCT02895100Phase 2Results posted
• A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative ColitisCompletedNCT02883452Phase 1Results posted
• Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.CompletedNCT02840721Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)CompletedNCT02819635Phase 2/3Results posted
• Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UCTerminatedNCT02808390Phase 2Results posted
• Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative ColitisTerminatedNCT02764229Phase 2Results posted
• An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative ColitisCompletedNCT02762500Phase 2Results posted
• Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)CompletedNCT02750800Results posted
• Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's DiseaseTerminatedNCT02743806Phase 4Results posted
• Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative ColitisCompletedNCT02647866Phase 2Results posted
• Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative ColitisCompletedNCT02632175Phase 3Results posted
• A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's DiseaseCompletedNCT02620046Phase 3Results posted
• A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative ColitisCompletedNCT02618187Phase 1Results posted
• Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative ColitisCompletedNCT02611830Phase 3Results posted
• An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative ColitisCompletedNCT02601300Phase 2Results posted
• A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative ColitisCompletedNCT02589665Phase 2Results posted
• Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's DiseaseCompletedNCT02559713Phase 4Results posted
• Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative ColitisCompletedNCT02536404Phase 2Results posted
• An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative ColitisCompletedNCT02531126Phase 3Results posted
• Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)CompletedNCT02522780Phase 3Results posted
• Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)CompletedNCT02522767Phase 3Results posted
• Safety and Efficacy of Andecaliximab (GS-5745) in Adults With Moderately to Severely Active Ulcerative ColitisTerminatedNCT02520284Phase 2/3Results posted
• A Prospective Non-interventional Multicenter Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in Routine Clinical PracticeCompletedNCT02499263Results posted
• An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative ColitisCompletedNCT02497469Phase 3Results posted
• A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-MCompletedNCT02493712Phase 2Results posted
• Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative ColitisCompletedNCT02447302Phase 2Results posted
• Correlation of Infliximab Levels With Outcomes in Ulcerative ColitisCompletedNCT02438410Results posted
• Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative ColitisCompletedNCT02435992Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT02407236Phase 3Results posted
• Evaluation of 3D Visualization for Total ColectomyCompletedNCT02370056Not applicableResults posted
• Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in RemissionCompletedNCT02365480Phase 1Results posted
• Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's ColitisCompletedNCT02330653Phase 1/2Results posted
• To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)TerminatedNCT02326155Results posted
• Correlation of Soluble Suppression of Tumorigenicity 2 (ST2) With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).CompletedNCT02318667Phase 4Results posted
• Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease TherapeuticsCompletedNCT02316678Results posted
• Efficacy and Safety Study of Apremilast to Treat Active Ulcerative ColitisCompletedNCT02289417Phase 2Results posted
• Low Dose IL-2 for Ulcerative ColitisCompletedNCT02200445Phase 1Results posted
• A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) InhibitorsCompletedNCT02171429Phase 3Results posted
• A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) InhibitorsCompletedNCT02165215Phase 3Results posted
• A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) InhibitorsCompletedNCT02163759Phase 3Results posted
• Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027)CompletedNCT02155335Phase 4Results posted
• A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) InhibitorsCompletedNCT02136069Phase 3Results posted
• Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III StudiesTerminatedNCT02118584Phase 3Results posted
• Fecal Microbiota Transplantation in Pediatric PatientsCompletedNCT02108821Phase 1Results posted
• A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) InhibitorsCompletedNCT02100696Phase 3Results posted
• Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative ColitisCompletedNCT02093663Phase 3Results posted
• Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuoTerminatedNCT02092389Results posted
• Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032)CompletedNCT02092285Phase 4Results posted
• Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative ColitisCompletedNCT02065622Phase 3Results posted
• Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative ColitisCompletedNCT02065557Phase 3Results posted
• FMT in Ulcerative Colitis-Associated PouchitisCompletedNCT02049502Phase 2Results posted
• Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative ColitisCompletedNCT02039505Phase 3Results posted
• MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis PatientsCompletedNCT01959165Phase 2Results posted
• Trichuris Suis Ova Treatment in Left-sided Ulcerative ColitisTerminatedNCT01953354Phase 2Results posted
• Special Investigation in Patients With Ulcerative ColitisCompletedNCT01947816Results posted
• TP05 for the Treatment of Mild to Moderate Active Ulcerative Colitis (UC)CompletedNCT01903252Phase 3Results posted
• HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative ColitisTerminatedNCT01882764Phase 3Results posted
• A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis.CompletedNCT01863771Phase 3Results posted
• Web-based Monitoring in Children and Adolescents With Inflammatory Bowel DiseaseCompletedNCT01860651Not applicableResults posted
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative ColitisCompletedNCT01831427Phase 1Results posted
• A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative ColitisTerminatedNCT01805791Phase 3Results posted
• A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)CompletedNCT01804166Phase 4Results posted
• Long-Term Safety Of PF-00547659 In Ulcerative ColitisCompletedNCT01771809Phase 2Results posted
• Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical PracticeCompletedNCT01768858Results posted
• Bacteriotherapy in Pediatric Inflammatory Bowel DiseaseCompletedNCT01757964Phase 1Results posted
• Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)TerminatedNCT01716039Phase 2Results posted
• A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative ColitisTerminatedNCT01706159Phase 2Results posted
• Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative ColitisCompletedNCT01694485Phase 2Results posted
• Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)CompletedNCT01692743Phase 3Results posted
• Efficacy of Gralise® for Chronic Pelvic PainTerminatedNCT01678911Phase 4Results posted
• Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative ColitisTerminatedNCT01671956Phase 2Results posted
• Efficacy and Safety Study of Ozanimod in Ulcerative ColitisCompletedNCT01647516Phase 2Results posted
• A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative ColitisCompletedNCT01620255Phase 2Results posted
• A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)CompletedNCT01562314Phase 2Results posted
• A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice SettingCompletedNCT01550965Phase 3Results posted

← Colitis, Ulcerative overview